Table 1.
Patient characteristics
| HG (N = 956) | cLFLG (N = 447) | pLFLG (N = 373) | Total (N = 1776) | p value | |
|---|---|---|---|---|---|
| Male sex | 440 (46.0%) | 311 (69.6%) | 166 (44.5%) | 917 (51.6%) | < 0.01 |
| Age (years) | 81.2 [77.3–85.4] | 82.0 [77.4–86.3] | 82.2 [78.3–85.6] | 81.7 [77.5–85.7] | 0.19 |
| Body mass index (kg/m2) | 25.8 [23.4–29.4] | 25.5 [22.7–28.8] | 26.0 [23.8–28.7] | 25.8 [23.4–29.1] | 0.19 |
| Body surface area (m2) | 1.8 [1.7–2.0] | 1.9 [1.7–2.0] | 1.8 [1.7–2.0] | 1.8 [1.7–2.0] | 0.02 |
| STS-score | 3.0 [2.0–5.0] | 5.0 [3.0–7.3] | 3.9 [2.2–6.0] | 3.8 [2.1–6.0] | < 0.01 |
| Diabetes mellitus type 2 | 249 (28.3%) | 148 (35.3%) | 118 (33.8%) | 515 (31.2%) | 0.02 |
| Hypertension | 785 (88.7%) | 392 (92.9%) | 324 (92.8%) | 1501 (90.6%) | 0.01 |
| Smoker (active or past) | 174 (19.7%) | 103 (24.5%) | 54 (15.4%) | 331 (20.0%) | < 0.01 |
| Hypercholesterolemia | 351 (40.3%) | 170 (41.3%) | 161 (46.4%) | 682 (41.8%) | 0.14 |
| Positive family history | 86 (9.0%) | 35 (7.8%) | 46 (12.3%) | 167 (9.4%) | 0.07 |
| Chronic kidney disease | 367 (38.4%) | 279 (62.4%) | 178 (47.7%) | 824 (46.4%) | < 0.01 |
| Atrial fibrillation | 193 (20.2%) | 163 (36.5%) | 155 (41.6%) | 511 (28.8%) | < 0.01 |
| Coronary artery disease | 500 (56.2%) | 314 (73.5%) | 222 (63.4%) | 1036 (62.2%) | < 0.01 |
| Prior MI | 107 (11.2%) | 119 (26.6%) | 50 (13.4%) | 276 (15.5%) | < 0.01 |
| Prior PCI | 258 (29.3%) | 195 (46.2%) | 113 (32.3%) | 566 (34.2%) | < 0.01 |
Data are presented as n (%) or median [IQR]. A p value of < 0.05 was considered significant
STS-score society of thoracic surgeons score, MI myocardial infarction, PCI percutaneous coronary intervention